Lv4
470 积分 2022-06-01 加入
Single CAR-t infusion during front-line consolidation induces deep and sustained remission in newly diagnosed adult ph+b- ALL: A prospective phase 2 study
10小时前
求助中
Post-CAR-T Cell Therapy (Consolidation and Relapse): Lymphoma
10小时前
已完结
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
11小时前
已完结
Real-world analysis of axicabtagene ciloleucel (axi-cel) as consolidation therapy following first-line treatment in B-cell lymphoma with high-risk factors
11小时前
待确认
High-risk MCL: recognition and treatment
2个月前
已完结
Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis
2个月前
已关闭
CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations
4个月前
已完结
449 | BRIDGING TO CAR‐T CELL THERAPY IN LARGE B‐CELL LYMPHOMA WITH EITHER CONVENTIONAL THERAPY OR THE CD3xCD20 BISPECIFIC ANTIBODY GLOFITAMAB
4个月前
已关闭
Allogeneic transplantation after failure of chimeric antigen receptor‐T cells and exposure to bispecific antibodies: Feasibility, safety and survival outcomes
5个月前
已完结
Treatment of Diffuse Large B-cell Lymphoma Progressing or Relapsing after Chimeric Antigen Receptor T-cell Therapy
5个月前
已完结
皖公网安备34019202002308
